Titlebook: Comprehensive lipid testing and management; Lars A. Carlson Book 2011 Springer Healthcare 2011 Cholestrol.Coronary heart disease.Diabetes.

frustrate

書(shū)目名稱(chēng)Comprehensive lipid testing and management影響因子(影響力)




書(shū)目名稱(chēng)Comprehensive lipid testing and management影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Comprehensive lipid testing and management網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Comprehensive lipid testing and management網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Comprehensive lipid testing and management被引頻次




書(shū)目名稱(chēng)Comprehensive lipid testing and management被引頻次學(xué)科排名




書(shū)目名稱(chēng)Comprehensive lipid testing and management年度引用




書(shū)目名稱(chēng)Comprehensive lipid testing and management年度引用學(xué)科排名




書(shū)目名稱(chēng)Comprehensive lipid testing and management讀者反饋




書(shū)目名稱(chēng)Comprehensive lipid testing and management讀者反饋學(xué)科排名

Ornithologist

使饑餓

Lipid profiless to determine LDL-C and HDL-C became available in routine clinical practice. Subsequently, attempts to advance the evaluation of risk for clinical atherosclerosis have continued, in order to improve prevention and treatment of the disease. In this respect, as described later in this chapter, two ma

acheon

Lipid testing and prediction of coronary heart diseaseerol, blood pressure, smoking and diabetes [14]. Risk prediction based on Framingham data was improved in the 1980s by addition of the ‘negative’ lipid risk factor HDL-C [15]. Subsequently, there have been further developments in risk prediction. These and the present status of risk prediction in cl

可耕種

話(huà)

話(huà)

byline

弄臟

archers, general practitioners, and primary care physicians.Cardiovascular disease is a major cause of morbidity and mortality in developed countries. Measurement of blood of lipids and lipoproteins has become one of the most frequently performed assays in clinical chemistry laboratories, reflecting

不法行為

https://doi.org/10.1007/978-3-8350-9259-4ausing coronary heart disease (CHD), cerebrovascular diseases and peripheral vascular diseases which here are called clinical atherosclerosis, cause considerable morbidity and disability. The major manifestations of clinical atherosclerosis are listed in Figure 1.1.